elina o erra - Infectious Diseases

Author Information

Elina O. Erra is affiliated with the Meilahti Vaccine Research Center (MeVac), Department of Infectious Diseases at the University of Helsinki and Helsinki University Hospital in Helsinki, Finland. Her research primarily focuses on infectious diseases, with a strong emphasis on vaccine-related studies and the prevention of viral infections.

Research Contributions

Elina O. Erra has made significant contributions to the field of infectious diseases, particularly in the study of vaccines and viral infections. Her work includes research on the effectiveness of vaccination schedules, such as a study comparing three-dose versus four-dose primary schedules for the tick-borne encephalitis vaccine in individuals aged 50 and older. Her research also extends to the transmission dynamics of SARS-CoV-2 in school settings, the prevention of Japanese encephalitis, and the diagnosis and prevention of dengue in travelers. Her studies often focus on the clinical efficacy and cross-protection of vaccines, providing valuable insights into public health and vaccine strategies.

Aliases

Elina O. Erra is also known by the aliases Elina Erra and Elina O Erra.

Publication and Citation Metrics

Publication Count	10
Citation Count	331
H-index	7

Publications:

Three-dose versus four-dose primary schedules for tick-borne encephalitis (TBE) vaccine FSME-immun for those aged 50 years or older: A single-centre, open-label, randomized controlled trial.

DOI: 10.1016/j.vaccine.2022.01.022

Year: 2022

Transmission of SARS-CoV-2 following exposure in school settings: experience from two Helsinki area exposure incidents.

DOI: 10.1101/2020.07.20.20156018

Year: 2020

The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis

DOI: 10.1586/14760584.2015.1061939

Year: 2015

Dengue in Travelers: Kinetics of Viremia and NS1 Antigenemia and Their Associations with Clinical Parameters

DOI: 10.1371/journal.pone.0065900

Year: 2013

Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes

DOI: 10.1093/cid/cis883

Year: 2013

Flavivirus Infections in Travelers: Insights into Prevention of Japanese Encephalitis and Diagnostics of Dengue

DOI:

Year: 2013

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study.

DOI: 10.1016/j.vaccine.2013.10.055

Year: 2013

A Single Dose of Vero Cell–Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain–Derived JE Vaccines

DOI: 10.1093/cid/cis542

Year: 2012

Early diagnosis of dengue in travelers: comparison of a novel real-time RT-PCR, NS1 antigen detection and serology.

DOI: 10.1016/j.jcv.2009.11.001

Year: 2010

What is the Current Research Focus?

What are Anopheles Mosquitoes?

Why is Respiratory Hygiene Important?

What are the Risk Factors for HPV Infection?

What is Real-Time PCR?

How Do Immunodeficiency Disorders Affect the Body?

Is There a Cure for Herpes?

How Does Glycolysis Relate to Infectious Diseases?

Why is Fever Management Important in Infectious Diseases?

What is Hepatitis B?

Partnered Content Networks

Relevant Topics